These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 14645596)

  • 1. Characterization of murine leukemia virus restriction in mammals.
    Besnier C; Ylinen L; Strange B; Lister A; Takeuchi Y; Goff SP; Towers GJ
    J Virol; 2003 Dec; 77(24):13403-6. PubMed ID: 14645596
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression levels of Fv1: effects on retroviral restriction specificities.
    Li W; Yap MW; Voss V; Stoye JP
    Retrovirology; 2016 Jun; 13(1):42. PubMed ID: 27342974
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The human TRIM5alpha restriction factor mediates accelerated uncoating of the N-tropic murine leukemia virus capsid.
    Perron MJ; Stremlau M; Lee M; Javanbakht H; Song B; Sodroski J
    J Virol; 2007 Mar; 81(5):2138-48. PubMed ID: 17135314
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Generation and characterization of a stable full-length ecotropic murine leukemia virus molecular clone that produces novel phenotypes to Fv1 restriction.
    Bae EH; Park SH; Park SM; Park JW; Lim MS; Jung YT
    J Microbiol Biotechnol; 2008 Apr; 18(4):799-804. PubMed ID: 18467880
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fv1-like restriction of N-tropic replication-competent murine leukaemia viruses in mCAT-1-expressing human cells.
    Aagaard L; Mikkelsen JG; Warming S; Duch M; Pedersen FS
    J Gen Virol; 2002 Feb; 83(Pt 2):439-442. PubMed ID: 11807237
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A conserved mechanism of retrovirus restriction in mammals.
    Towers G; Bock M; Martin S; Takeuchi Y; Stoye JP; Danos O
    Proc Natl Acad Sci U S A; 2000 Oct; 97(22):12295-9. PubMed ID: 11027299
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complex determinants within the Moloney murine leukemia virus capsid modulate susceptibility of the virus to Fv1 and Ref1-mediated restriction.
    Ulm JW; Perron M; Sodroski J; C Mulligan R
    Virology; 2007 Jul; 363(2):245-55. PubMed ID: 17343889
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of a transient assay for studying the genetic determinants of Fv1 restriction.
    Bock M; Bishop KN; Towers G; Stoye JP
    J Virol; 2000 Aug; 74(16):7422-30. PubMed ID: 10906195
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Abrogation of Ref1 retrovirus restriction in human cells.
    Towers G; Collins M; Takeuchi Y
    J Virol; 2002 Mar; 76(5):2548-50. PubMed ID: 11836433
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of producer cell-dependent restriction of murine leukemia virus replication.
    Serhan F; Jourdan N; Saleun S; Moullier P; Duisit G
    J Virol; 2002 Jul; 76(13):6609-17. PubMed ID: 12050374
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dynamics and restriction of murine leukemia virus cores in mitotic and interphase cells.
    Elis E; Ehrlich M; Bacharach E
    Retrovirology; 2015 Nov; 12():95. PubMed ID: 26577111
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of syncytia by neuropathogenic murine leukemia viruses depends on receptor density, host cell determinants, and the intrinsic fusion potential of envelope protein.
    Chung M; Kizhatil K; Albritton LM; Gaulton GN
    J Virol; 1999 Nov; 73(11):9377-85. PubMed ID: 10516046
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retroviral capsid determinants of Fv1 NB and NR tropism.
    Stevens A; Bock M; Ellis S; LeTissier P; Bishop KN; Yap MW; Taylor W; Stoye JP
    J Virol; 2004 Sep; 78(18):9592-8. PubMed ID: 15331691
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Restriction of multiple divergent retroviruses by Lv1 and Ref1.
    Hatziioannou T; Cowan S; Goff SP; Bieniasz PD; Towers GJ
    EMBO J; 2003 Feb; 22(3):385-94. PubMed ID: 12554640
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Retroviral restriction factors Fv1 and TRIM5alpha act independently and can compete for incoming virus before reverse transcription.
    Passerini LD; Keckesova Z; Towers GJ
    J Virol; 2006 Mar; 80(5):2100-5. PubMed ID: 16474118
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heparin binds to murine leukemia virus and inhibits Env-independent attachment and infection.
    Walker SJ; Pizzato M; Takeuchi Y; Devereux S
    J Virol; 2002 Jul; 76(14):6909-18. PubMed ID: 12072492
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Capsid processing requirements for abrogation of Fv1 and Ref1 restriction.
    Dodding MP; Bock M; Yap MW; Stoye JP
    J Virol; 2005 Aug; 79(16):10571-7. PubMed ID: 16051849
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evolution of functional and sequence variants of the mammalian XPR1 receptor for mouse xenotropic gammaretroviruses and the human-derived retrovirus XMRV.
    Yan Y; Liu Q; Wollenberg K; Martin C; Buckler-White A; Kozak CA
    J Virol; 2010 Nov; 84(22):11970-80. PubMed ID: 20844050
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Murine leukemia virus glycosylated Gag blocks apolipoprotein B editing complex 3 and cytosolic sensor access to the reverse transcription complex.
    Stavrou S; Nitta T; Kotla S; Ha D; Nagashima K; Rein AR; Fan H; Ross SR
    Proc Natl Acad Sci U S A; 2013 May; 110(22):9078-83. PubMed ID: 23671100
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of the regions of Fv1 necessary for murine leukemia virus restriction.
    Bishop KN; Bock M; Towers G; Stoye JP
    J Virol; 2001 Jun; 75(11):5182-8. PubMed ID: 11333899
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.